State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.45B |
| 2 |
Analog Devices
ADI
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$1.24B |
| 4 |
Tesla
TSLA
|
+$989M |
| 5 |
Match Group
MTCH
|
+$950M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.84B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.43B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$629M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$528M |
| 5 |
Oracle
ORCL
|
+$440M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.19% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.28% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRS
2576
DELISTED
Verso Corporation
VRS
| $13.6M | ﹤0.01% |
656,403
+86,916
| +15% | +$1.68M |
|
|
BTRS
2577
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $13.6M | ﹤0.01% |
1,274,305
+186,277
| +17% | +$2.15M |
|
|
XONE
2578
DELISTED
The ExOne Company
XONE
| $13.5M | ﹤0.01% |
577,895
+35,289
| +7% | +$740K |
|
2579
Amneal Pharmaceuticals
AMRX
$5.79B
| $13.5M | ﹤0.01% |
2,529,797
-209,018
| -8% | -$1.05M |
|
2580
ANI Pharmaceuticals
ANIP
$1.78B
| $13.5M | ﹤0.01% |
411,020
+10,985
| +3% | +$341K |
|
|
BBL
2581
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $13.5M | ﹤0.01% |
270,309
+265,463
| +5,478% | +$16M |
|
|
NIU
2582
Niu Technologies
NIU
$193M
| $13.4M | ﹤0.01% |
580,288
+31,000
| +6% | +$826K |
|
|
AXIA
2583
AXIA Energia
AXIA
$23.3B
| $13.4M | ﹤0.01% |
2,388,835
+40,852
| +2% | +$248K |
|
|
ABB
2584
DELISTED
ABB Ltd
ABB
| $13.4M | ﹤0.01% |
401,408
+18,066
| +5% | +$656K |
|
2585
American Vanguard Corp
AVD
$68.9M
| $13.4M | ﹤0.01% |
887,066
+5,253
| +0.6% | +$83K |
|
2586
Invivyd
IVVD
$218M
| $13.4M | ﹤0.01% |
+316,078
| New | +$11.7M |
|
2587
Byline Bancorp
BY
$1.76B
| $13.3M | ﹤0.01% |
543,411
+55,243
| +11% | +$1.32M |
|
|
RVI
2588
DELISTED
Retail Value Inc. Common Shares
RVI
| $13.3M | ﹤0.01% |
5,518,327
+82,525
| +2% | +$187K |
|
2589
Luxfer Holdings
LXFR
$458M
| $13.3M | ﹤0.01% |
677,442
+3,799
| +0.6% | +$78.4K |
|
|
DX
2590
Dynex Capital
DX
$3.21B
| $13.3M | ﹤0.01% |
763,131
+57,059
| +8% | +$1.01M |
|
|
ELAT
2591
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $13.1M | ﹤0.01% |
263,200
+35,000
| +15% | +$1.82M |
|
|
DFTX
2592
Definium Therapeutics
DFTX
$6.12B
| $13.1M | ﹤0.01% |
375,606
+77,275
| +26% | +$3.34M |
|
|
ACRE
2593
Ares Commercial Real Estate
ACRE
$270M
| $13.1M | ﹤0.01% |
850,967
+107,602
| +14% | +$1.63M |
|
2594
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $13.1M | ﹤0.01% |
647,772
-87,976
| -12% | -$1.69M |
|
2595
Modine Manufacturing
MOD
$10.4B
| $13.1M | ﹤0.01% |
1,153,508
-62,138
| -5% | -$868K |
|
|
NGM
2596
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $13.1M | ﹤0.01% |
621,163
+26,545
| +4% | +$584K |
|
2597
SFL Corp
SFL
$1.61B
| $13M | ﹤0.01% |
1,556,395
+31,757
| +2% | +$240K |
|
2598
Marcus Corp
MCS
$945M
| $13M | ﹤0.01% |
746,837
-36,249
| -5% | -$591K |
|
2599
Avita Medical
RCEL
$240M
| $13M | ﹤0.01% |
732,875
-80,254
| -10% | -$1.51M |
|
2600
Blue Owl Capital
OWL
$18.5B
| $13M | ﹤0.01% |
+833,600
| New | +$11.6M |
|
Similar funds
State Street's Q3 2021 Portfolio in Review
As of Q3 2021, State Street held 4,773 positions worth $1.89T, down 0.28% from $1.9T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q3 2021 filing shows 298 new, 2,370 increased, 1,521 reduced and 88 closed positions. Its largest new stake was GXO Logistics: 2,520,396 shares worth $198M. The largest sale was Alexion Pharmaceuticals, an estimated $1.84B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q3 2021 buy was GXO Logistics: 2,520,396 shares worth $198M.
- State Street added most to Moderna in Q3 2021, an estimated $2.45B increase.
- State Street's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $629M.
- State Street fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.84B.
- State Street's ten largest holdings make up 21% of its $1.89T portfolio in Q3 2021.
- State Street opened 298 new positions and closed 88 in Q3 2021.
- State Street's portfolio value fell 0.28% quarter-over-quarter to $1.89T.
Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.